ArticleCureus2025
Fatal Lead Toxicity From Ayurvedic Supplements in a Patient With Parkinson's Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead poisoning is rare in adults, particularly when the source of exposure is not immediately apparent. This case describes a 76-year-old woman with Parkinson's disease who presented with altered mental status after taking Ayurvedic supplements for several weeks. Clinical evaluation revealed a blood lead level greater than 90 µg/dL (measured after her supplement use was identified) and abdominal imaging that demonstrated radiopaque material throughout the colon, findings consistent with lead ingestion. Although chelation therapy was initiated promptly, her condition worsened due to progressive neurologic decline and the development of secondary infections. After discussions with her family, the focus of care was transitioned to comfort measures. This case highlights the importance of obtaining a thorough medication history, including over-the-counter and alternative therapies, both on admission and throughout hospitalization. It also underscores the serious risks associated with heavy metal exposure, particularly in patients with preexisting neurologic disorders, and the need for early, guideline-based management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.